T 0034/10 (Extracellular domain influenza M2 membrane protein/VLAAMS) of 12.02.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T003410.20140212
- Date of decision
- 12 February 2014
- Case number
- T 0034/10
- Petition for review of
- -
- Application number
- 98946321.1
- IPC class
- C12N 15/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- IMMUNOPROTECTIVE INFLUENZA ANTIGEN AND ITS USE IN VACCINATION
- Applicant name
- Vlaams Interuniversitair Instituut voor
Biotechnologie vzw. - Opponent name
- Vaxinnate Corporation
MERCK + CO. INC.
Cytos Biotechnology AG - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Admissibility of Main Request and Auxiliary Requests 1 and 2 (no)
Admissibility of Auxiliary Requests 3 and 4 (yes)
Auxiliary Request 3 - clarity (no)
Auxiliary Request 4 - all requirements of the EPC (yes) - Catchword
- -
- Cited cases
- T 0019/90
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent as amended on the basis of claims 1 to 15 of Auxiliary Request 4 filed with letter dated 23 March 2010 and a description to be adapted thereto.